Your browser doesn't support javascript.
The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics.
Sinha, Michael S; Powers, John H; Kesselheim, Aaron S.
  • Sinha MS; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Powers JH; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, Massachusetts, USA.
  • Kesselheim AS; George Washington University School of Medicine, Washington, District of Columbia, USA.
J Infect Dis ; 223(9): 1506-1509, 2021 05 20.
Article in English | MEDLINE | ID: covidwho-1243481
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Bacterial Agents / Motivation Language: English Journal: J Infect Dis Year: 2021 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Bacterial Agents / Motivation Language: English Journal: J Infect Dis Year: 2021 Document Type: Article Affiliation country: Infdis